Toggle navigation
Home
Search
Services
Blog
Contact
About
CD4 Based in Vivo Imaging Agent for HIV 1 Infection
Allaway, Graham P.
Progenics Pharmaceuticals, Inc., Tarrytown, NY, United States
Search 16 grants from Graham Allaway
Search grants from Progenics Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
New Therapeutic Approaches for Hutchinson-Gilford Progeria Syndrome
LCPUFA Status and Birth Outcome in India
IgG subclasses in SIV pathogenesis
Multisubstrate Enzyme Inhibitors
Inhibition of IN Vitro Transformation by Retinoids
Recently added grants:
Developing a Screening Protocol for Family Caregivers of Older Persons with and without Dementia Seen in Primary Care
The flavin-centric metabolic lifestyle of Treponema pallidum
New Statistical Methods for Multicenter Multimodal Longitudinal Neuroimaging Analysis
Cardiac microlesion formation during invasive pneumococcal disease
Regulation of the physiology and function of the digestive vacuole in Toxoplasma gondii
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44AI036028-02A1
Application #
2004110
Study Section
Special Emphasis Panel (ZRG7-SSS-4 (02))
Project Start
1994-05-01
Project End
1998-09-29
Budget Start
1996-09-30
Budget End
1997-09-29
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Progenics Pharmaceuticals, Inc.
Department
Type
DUNS #
945494490
City
Tarrytown
State
NY
Country
United States
Zip Code
10591
Related projects
NIH 1997
R44 AI
CD4 Based in Vivo Imaging Agent for HIV 1 Infection
Allaway, Graham P. / Progenics Pharmaceuticals, Inc.
NIH 1996
R44 AI
CD4 Based in Vivo Imaging Agent for HIV 1 Infection
Allaway, Graham P. / Progenics Pharmaceuticals, Inc.
Comments
Be the first to comment on Graham Allaway's grant